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The fragmentation of peptides, to which a positive charge is attached at the N-terminus, was
studied by matrix-assisted laser desorption/ionization postsource decay mass spectrometry.
In these experiments, the tris[(2,4,6-trimethoxyphenyl)phosphonium] acetyl group is co-
valently attached. The main advantage of this modification is that the resulting spectra are
simplified and the fragment ions observed consist predominantly of an-type ions. We report
the results for charge-derivatized peptides formed following enzymatic digestion of phos-
phoenolpyruvate carboxykinase. Specific fragmentation of bonds within aspargine and
threonine residues are observed and are discussed. The understanding of the mechanistic
aspects of the fragmentation process is essential to formulate a simple and straightforward
mass spectrometric strategy for peptide sequencing using these charged derivatives. (J Am
Soc Mass Spectrom 2000, 11, 145–152) © 2000 American Society for Mass Spectrometry
In conventional peptide sequencing based on tandemmass spectrometry, protonated peptide molecules[M 1 H]1 are first selected. These either dissociate
spontaneously or dissociate following collisional activa-
tion, to yield a variety of N-terminal and C-terminal
fragment ions from cleavage of peptide backbone CHR–
C(O), C(O)–NH, and NH–CHR bonds. The interpreta-
tion of the resulting mass spectra is complicated by the
rich chemistry that can take place [1]. When each
skeletal bond cleaves, two possible ions can be gener-
ated, commonly referred to as an, bn, cn, xn, yn, and zn
fragment ions (where n is equal to the number of
sidechains in the fragment ion). Also, multiple skeletal
bonds can be broken to yield internal fragment ions.
Elimination of portions of side chains can accompany
skeletal bond breakage as well, yielding dn, vn, and wn
ions. In some cases, fragmentation is limited, and insuf-
ficient information is available to determine a complete
sequence. In other cases, fragmentation is extensive,
and the available ion current becomes distributed over
many channels of information. That is, all mass spectral
peaks are of low intensity, reducing the ability to
perform accurate mass determinations and peak detec-
tion.
An additional complication is the fact that the pro-
tonated peptide’s fragmentation pattern is highly de-
pendent on the presence, number, and position of basic
residues in the peptide. When a highly basic residue is
present, it appears to be the preferred site of protona-
tion. Cleavage of skeletal bonds remote from the site of
protonation follows different mechanisms than those
proposed for reactions controlled by the charge site. The
distribution of N- and C-terminal fragment ions can be
dominated by the location of the basic residues. Thus,
many characteristics of the spectra can change, depend-
ing on the amino acid residues present, limiting our
abilities to reliably extract structural information from
mass spectra.
Chemical derivatization of peptides, to attach a fixed
positive charge at one terminus, is an approach that was
developed in the context of fast atom bombardment
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(FAB) mass spectrometry. The use of a variety of
charged groups has been investigated [2–11]. Charged
derivatives are useful in FAB, because they increase the
sensitivity of the experiment, yielding more intense
signals. Charged groups that have been investigated
yield variable results in terms of the fragment ions that
are formed from the charged precursor, C1. Although
some charged groups are stable, and fragmentation
along the peptide backbone occurs, other charged
groups fragment easily, yielding little structural infor-
mation for the attached peptide. We have shown that
charged derivatives are very useful when ions are
generated by matrix-assisted laser desorption/ioniza-
tion (MALDI) [7, 8, 11]. We have also demonstrated that
the tris(trimethoxyphenyl)phosphonium group, with
an acetyl linker (TMPP1 2Ac) to the N-terminus, is
stable and is an ideal charged tag for peptides. In the
MALDI-postsource decay (PSD) experiment, charge-
derivatized peptides fragment by forming an-type ions,
upon cleavage of backbone CHR–C(O) bonds. There are
some residues that yield additional fragment ions, but
the spectra are relatively simple to interpret.
In our initial report [8], fragmentation patterns of
three TMPP1 2Ac-derivatized peptides were dis-
cussed. These three examples were selected to provide
information on the bond cleavages within 10 different
amino acid residues, approximately half of those that
may be encountered in peptides. Glycine residues at
position n yielded only a small an ion peak. The
residues V, A, M, S, L, F, and I only fragment to form an
ions as well. One unique case is proline (P), which does
not yield any fragment ions. The absence of an ions from
P suggested that, when CHR–C(O) bonds cleave in
these charge-remote processes, an accompanying H
shift from the N of the residue in the nth position occurs
to yield an an ion, Scheme 1. Also, aspartic acid (D)
residues at position n form a distinctive triplet of
fragment ions {bn, dn, and cn 2 1} for which structures
and mechanisms have been proposed. These are shown
in Schemes 2–4, in generalized forms that are consistent
with data for additional residues presented here. Once
the residue-specific fragmentation processes are de-
fined, spectral interpretation becomes straightforward.
In this work, we discuss the residue-specific frag-
mentations of the remaining possible amino acid resi-
dues, and extend our continuing efforts to study
charge-derivatized peptides that have been formed by
enzymatic digestion of proteins. The charge derivatiza-
tion method provides an advantage in determining
peptide sequences from tandem mass spectrometric
data and can easily be adapted to automated methods
for de novo peptide sequencing [12].
Experimental
Materials
The a-cyano-4-hydroxycinnamic acid MALDI matrix
was obtained from Aldrich Chemical (Milwaukee, WI).
Sequencing grade trypsin was obtained from the Pro-
mega (Madison, WI) and sequencing grade chymotryp-
sin from Boehringer Mannheim (Indianapolis, IN). The
reagent [TMPP1 2 Ac 2 SC6F5][Br
2] was prepared by
first reacting bromoacetyl bromide with pentafluoro-
thiophenol, and then adding tris-(2,4,6-trimethozyphe-
nyl)phosphine to produce the salt [8, 9]. All tryptic
peptides used in this study were generated from phos-
phoenolpyruvate carboxykinase, which was prepared
as previously described [13].
Derivatization Reaction
For a typical digestion, 20 mg of protein were prepared
at a concentration of 2 mg/mL in 70 mM phosphate
buffer (pH 8.1). The protein was then thermally dena-
tured (5 to 10 min at 60 °C). The reaction mixture was
incubated at 37 °C with trypsin (wt. ratio of enzyme:
protein, 1:20) for 1–2 h. The derivatization reaction was
performed by mixing reagent with the tryptic digest
mixture at a 50:1 ratio. The reaction occurred for ap-
Scheme 1
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proximately 30 min at room temperature. Purification
and isolation of the derivatized tryptic digest was
carried out using a microbore HPLC system equipped
with a 1 mm 3 150 mm Reliasil C18 column (Michrom
BioResources, Auburn, CA).
Methyl Ester Formation
Methanolic HCl was freshly prepared by adding 100 mL
of acetyl chloride to 1 mL of absolute methanol on ice
[14]. The HPLC fraction containing the charge-derivat-
ized peptides was dried in vacuo. Then, 20 mL of this
reagent was added. The reaction proceeds at room
temperature for 30 min, and the products are vacuum
dried. The resulting methyl esters were analyzed di-
rectly by MALDI-MS.
Mass Spectrometry
All spectra were obtained on a Voyager Elite reflectron
time-of-flight mass spectrometer (Perseptive Biosys-
tems, Framingham, MA) equipped with a nitrogen laser
(337 nm, 3-ns pulse). For PSD experiments, the acceler-
ation voltage was 20 kV, the intermediate accelerating
grid potential was set at 60%–70% of the accelerating
voltage, and a delayed extraction of 75–100 ns was
selected. Spectra were acquired as the average of 256
transients. PSD spectra were generated in the reflectron
mode, by stitching together portions of spectra obtained
at different mirror ratios. The matrix used for obtaining
all mass spectra was a-cyano-4-hydroxycinnamic acid,
dissolved in a saturated solution of 1% trifluoroacetic
acid in acetonitrile–water (1:1, v/v). Samples for mass
spectrometry were prepared by using 1 mL of derivat-
ized peptide solution (10 pmol/mL), mixed with 1 mL of
the matrix solution and applied to the stainless steel
sample plate. The mixture was air dried before insertion
into the mass spectrometer.
Results and Discussion
Rather than charge-derivatizing commonly used,
readily available peptides, and to create a specific focus
on the de novo mass spectrometry sequence determi-
nation of digestion products, the decision was made to
perform tryptic and chymotryptic digestions on a pro-
tein, and demonstrate the fragmentation chemistry of
the amino acid residues that remain to be studied, in
charge-derivatized peptides, with examples from these
mixtures. The protein chosen for digestion was phos-
phoenolpyruvate carboxykinase. The protein was di-
gested, derivatized, and fractionated by high-perfor-
mance liquid chromatography (HPLC). In the MALDI
spectra of the individual fractions, one or more intense
peaks were observed. From the PSD spectra, it can be
determined if the peak represents a charged derivative,
as well as the sequence of the peptide. From these
spectra, we have learned how various residues lead to
fragment ions, and some illustrative examples are
shown here.
Products of tryptic digestion are peptides that con-
tain a basic residue at the C-terminus. This can lead to
MS/MS mass spectra that contain C-terminal fragment
ions. To demonstrate the difference in spectra from
fragmentation of protonated peptides vs. charge-deri-
vatized peptides, consider the spectra shown in Figure
1 for the two forms of H–DALLENVVVR–OH. Figure
1A shows how the protonated peptide molecules frag-
ment under MALDI-PSD. There is a partial series of b
ions and a few y ions found, insufficient to clearly
establish the entire sequence. This particular peptide
also forms some internal fragment ions, e.g., LEN (b6y7)
shown in Figure 1A at m/z 357, however, such peaks are
not formed in a predictable way. The spectrum shown
in Figure 1B, and its interpretation, is very different. For
the charge-derivatized form of the peptide a series of an
Scheme 4
Figure 1. MALDI-PSD spectra of: (A) [H–DALLENVVVR–
OH]H1 and (B) charge-derivatized peptide [1]–DALLENVVVR–
OH. [1] is used to represent the TMPP1 2 Ac group.
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ions are found which establish the sequence. Because all
an ions are formed by cleavage of the same kind of
backbone peptide bond, the mass differences between
them are directly related to the residue masses. The
practical advantage of using the MALDI-PSD spectra of
TMPP1 2 Ac 2 derivatized peptides is that the se-
quence is derived from a minimal number of mass
spectral peaks, improved sensitivity, and the spectra are
easy to interpret. The interpretation of the spectrum
shown Figure 1B proceeds as follows: The first distinct
low m/z peak is due to the charged group, which has an
m/z of 572.19 (labeled as a0). The first N-terminal
residue can typically be determined by the mass differ-
ence between the charged group and the a1 ion. In this
example, the N-terminal D residue is identified by a set
of three unique peaks, a signature of D [8]. The a2 ion is
located 87 u above the absent a1. The next two distinct
mass peaks are observed at 113 and 226 u above a2; a
mass of 113 u corresponds to leucine or isoleucine. The
assignments of Leu are based on known PCK se-
quences. The a-type ions for the sub-sequence ENVVV
are indicated in the figure. The last amino acid residue
of the charge-derivatized peptide is identified by the
high mass peak corresponding to loss of the C-terminal
residue, here R. In addition to using this peptide to
demonstrate the difference between fragmentation of a
peptide in two ionic forms, it also provides an example
of the behavior of some residues that have not previ-
ously been discussed. The a5 peak in Figure 1B shows
that E residues yields only an ions. Also, the spectrum
shows that R at the C terminus yields a distinctive [C 2
R]1 peak at the high mass end of the spectrum. The
spectrum suggests that an N residue at position 6 yields
not only an a6 ion, but additional peaks of lower m/z
values. The next example provides a more clear indica-
tion of the behavior of the N residue.
Figure 2 shows a second case of a charge-derivatized
peptide. Like the example in Figure 1B, all of the an-type
ions are clearly distinguishable, and the C-terminal
residue is identified by the [C 2 K]1 peak, demonstrat-
ing the behavior of the K residue at this position. In the
spectrum as labeled, it can be clearly seen that aspara-
gine (N) yields a total of four fragment ions. We have
encountered more than 10 peptides containing aspara-
gine residues among the charge-derivatized proteolytic
peptides in the digestion mixtures, all of which demon-
strated this fragmentation pattern. In terms of spectral
interpretation, assume that the lower mass peaks a1 and
a2 were first assigned. The m/z difference between a2
(773) and the next peak (818) is 45 Da, less than that for
the smallest residue, glycine. Thus m/z 818 cannot be an
a3 ion, but indicates that the third residue is one which
forms additional fragments. Using residue masses
alone, the m/z 844 ion could be the a3 ion if the third
residue is A, and the m/z 870 ion could be an a3 ion if the
third residue is proline, however both could not be true.
Also, proline does not form an an ion [8]. The mass
difference between m/z 773 and 887 is consistent with
887 being the a3 ion with the third residue as aspara-
gine. The other ions then quickly are identified as
fragments formed by breaking other bonds within the
asparagine residue. The chemistry parallels what has
been observed for aspartic acid, not unexpected consid-
ering the structural similarities. However the N residue
forms an an ion as well. The an ion is accompanied by an
an 2 17 peak. We suggest that the an 2 17 peak evolves
directly from the an peak, as shown in Scheme 5. It
could not be easily formed in a single step from C1, as
are the other fragment ions, since a total of four bonds
are cleaved to form this ion. With m/z 887 identified as
a3 with the third residue being N, the next peak at m/z
1034 is consistent with the fourth residue being F, and
the sequence determination can be completed.
Figure 3 shows the spectrum of a third charge-
derivatized peptide, which provides information on the
behavior of the threonine (T) residue, and tryptophan
(W) at the C-terminus. As in previous examples, the
a-type ions from I and G are clearly identified. The
C-terminal tryptophan is characterized by the [C1 2
186] ion, analogous to the [C1 2 K] peak discussed in
Figure 2. MALDI-PSD spectrum of the bromide salt of [1]–VEN-
FK–OH. The peaks labeled with (*) correspond to [1]-related ions.
Scheme 5
Figure 3. MALDI-PSD spectrum of the bromide salt of [1]–IG-
GTW–OH.
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Figure 1B. Again, the mass difference between the 817
peak and the a3 peak, 45 Da, indicates that a residue has
been encountered which has a more complex fragmen-
tation pattern. This spectrum is consistent with those
obtained for other Thr-containing peptides. A Thr at
position n yields an ions as well as an 2 16, an 2 44,
and cn 2 1 peaks. These assignments were made by first
recognizing the m/z 873 peak as establishing the fourth
residue, and then correlating the intermediate peaks
with cleavage of other bonds within that residue. It is
interesting to note that the formation of cn ions for
underivatized peptides under FAB collision-induced
dissociation (CID) MS/MS has been reported before,
and it has been shown that the cleavage of the N–C
bond of the peptide backbone preceding a threonine
residue is promoted when fragmentation is N-terminal
directed [15]. We have established that, for TMPP1 2
Ac 2 peptide ions, cn 2 1 ion formation is promoted if
D, N, or T is the nth residue, as summarized in Scheme
4. We assumed that the an 2 16 species is due to a
1,2-elimination of methane in the sidechain following an
ion formation. Clearly, an ions may eliminate small
neutrals (e.g., Scheme 5) if facile pathways exist.
Also of note is the high mass peak assigned in Figure
3 as [C1 2 CO2]. In the spectra that we have collected
to date, this ion is present with noticeable intensity
when the C-terminal residue is W, Y, or F. Other than
this observation, we do not suggest that it carries
additional structural information. Elimination of small
molecules such as H2O, NH3, and CO2 from ionized
peptides is certainly common in other mass spectrom-
etry experiments such as FAB CID MS. Since the Thorne
mechanism [16] for C-terminal residue elimination,
Scheme 6, involves a H-shift from the carboxy group,
this would certainly create a situation that could lead to
CO2 elimination. However, the driving force for this
process with some residues at the C-terminus, but not
others, is not yet apparent. Additional insight into the
[C1 2 CO2] product is provided through the next ex-
ample.
Figure 4A shows a typical MALDI-PSD spectrum of
a derivatized tryptic peptide with a molecular weight
(underivatized) of 822. The C1 ion for the TMPP1 2
Ac 2 peptide is observed at m/z 1394. Because the mass
of the TMPP1 2 Ac group is known, the mass differ-
ence between it and the first peak at m/z 708 identifies
this peak as representing a1 ions, with the first residue
being Y. Subsequent peak assignments are easily made
with a table of residue masses, to yield the sequence
shown. Because this spectrum contains exclusively a-
type ions, it is very simple to interpret. This spectrum
shows that the previously uncharacterized residue, Y,
fragments to only yield an ions. The C-terminal lysine
residue is identified by the [C1 2 128] peak, corre-
sponding to the loss of the lysine residue. The mass of
this ion corresponds to [1]–YAEVLV–OH, and for-
mally involves a shift of the C-terminal OH group to the
N-terminal fragment upon cleavage of the V–K amide
bond. The mechanism for loss of the C-terminal residue
in protonated peptides has been proposed by Thorne et
al. [16], Scheme 6. This is an interesting process, since it
involves interaction of the last two C-terminal residues.
In the Thorne mechanism, the OH shift is only in a
formal sense—the O and H are proposed to shift
separately.
To investigate the elimination of the C-terminal
residue, an obvious experiment suggested by the
Scheme 6
Figure 4. (A) MALDI-PSD spectrum of the bromide salt of
[1]–YAEVLVK–OH, C1 5 m/z 1394. (B) The MALDI-PSD spec-
trum of the charge derivative of the dimethylated form of the same
peptide.
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Thorne work is to methylate the C-terminus and deter-
mine the effect of changing the terminal OH group to
OCH3. For this peptide, the glutamic acid residue is also
converted to the methyl ester upon addition of meth-
anolic HCl, so the PSD mass spectrum of the doubly
methylated peptide was obtained. That is, the peak for
the [C1 1 28] species was selected for PSD analysis.
The resulting spectrum is shown in Figure 4B. The
masses of the first two sequence ions are unmodified as
expected; the masses of the larger fragment ions, those
which contain the modified glutamic acid, shift as
expected by 14 u. The dramatic change is the disappear-
ance of the peak corresponding to K elimination, [C1 1
28 2 K]. This reinforces the assignment for this peak,
and the previously described mechanism involving a
shifting of the C-terminal OH group in two steps,
Scheme 6.
A comment should be made on the three residues (D,
N, and T) that yield multiple fragment ions. The N
residues yields dn and cn 2 1 peaks, similar to what was
previously discussed for D [8]. While aspartic acid and
asparagine are similar, N loses ammonia, forming an
an 2 17 peak, while an analogous peak (an 2 18) is not
observed for D. The energies required should be simi-
lar. If one considers ketene formation from CH3COOH
(via H2O loss) or from CH3CONH2 (via NH3 loss), both
processes are endothermic by approximately 34 kJ/mol
[17]. The difference between D, N, and T is that T and N
at the nth position form an ions, whereas D does not.
Thus, the an 2 17 peak is likely formed in a multistep
process, via the an peak as an intermediate (Scheme 5).
A similar case exists for T. One unique feature for this
residue is the formation of an an 2 44 peak in the PSD
spectrum. Again, the peak is observed for a residue
which also forms an an ion, so it is likely a subsequent
product, due to elimination of CH3CHO, possibly via a
1,2-elimination with a H shift from the OH group of the
sidechain onto the N-terminal fragment. An important
aspect of the proposed mechanisms is that, whether the
residue only forms an an ion or a set of ions, the species
formed only involve cleavage of bonds within the single
residue. This is, from an analytical standpoint, very
fortunate. It is also consistent with the observation that
all of the chemistry discussed for fragmentation of
TMPP1 2 Ac 2 derivatized peptides is residue spe-
cific, and is not influenced by the nature of the neigh-
boring residues.
Figure 5 shows the MALDI-PSD spectrum of a
charge-derivatized peptide containing glutamine (Q).
The N-terminal glutamine residue yields a clear a1 ion.
The remaining sequence LSGK produced the complete
a-type ion series; notice that d-type ions of Ile/Leu are
occasionally being observed in MALDI-PSD spectra of
charge-derivatized peptides, such as d2 ion in this
spectrum. Although the terminal amide functional
group of Q is the same as that for N, the additional CH2
group in the side chain makes the intermediates respon-
sible for the other fragment ions much less likely, so it
follows the simple path of a-type ion formation. The
unique ions formed for D, N, T are not only due to the
presence of a mobile H on the side chain, but in a
position where it can easily form key intermediates.
Figure 6 shows the MALDI-PSD spectrum of a larger
species, a charged derivative with a C1 m/z of 1996. The
PSD spectrum indicates that the peptide contains 13
residues, and the sequence was completely determined
from the spectrum. It is a predicted proteolytic diges-
tion product of phosphoenolpyruvate carboxykinase, as
are all examples in this paper. The spectrum was
interpreted using the residue-specific fragmentation
chemistry established here and in our earlier work [8].
The first three residues were clearly established by the
corresponding an ions, found at m/z 602, 749, and 878.
From the a3 peak, the next intense peak is at m/z 1020,
corresponding to a mass shift of 142, which does not
correlate with a residue mass. The mass differences
between the three peaks at m/z 1020, 1046, and 1118 are
indicative of a D residue (which would not form an a5
ion), which we have characterized previously. If the
peak at m/z 1118 is a b5 ion, as the pattern would
suggest, then the 4th residue would have a mass of 97,
which corresponds to proline. Proline at position 4
would not yield an a4 ion, so this portion of the
spectrum is now internally consistent with the first five
residues being GFEPD2. The remainder of the spec-
trum was interpreted by identifying the remaining an
ions, realizing that readily observable peaks at 1663 and
Figure 5. MALDI-PSD spectrum of the bromide salt of [1]–QLS-
GK–OH.
Figure 6. MALDI-PSD spectrum of the bromide salt of
[1]–GFEPDFVVLNSK–OH. To make the smaller peaks clearly
visible, the relative intensity scale was magnified such that the a3
peak is slightly off-scale.
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1594 were consistent with the presence of N at position
10, and recognizing the high mass peak formed by
elimination of a C-terminal K residue. Of course, the
sequence suggested by the fragment ions formed must
be consistent with the molecular weight of the peptide,
as constrained by the m/z value of the C1 peak.
A comparison of the spectra shown in this paper
reveals that, while some residues will yield multiple
fragments, the relative intensities of these triplets/
quartets of peaks are not necessarily constant. Thus, it is
important to realize the possibilities, and to understand
that the S/N may not be sufficient to observe all peaks
in a cluster evolving from a particular residue. Surely,
relative intensities of peaks in these PSD spectra are not
only determined by the residue in which a skeletal bond
is cleaved, but also secondary structural aspects.
One residue which has not yet been found in a
charged derivative that has been presented is histidine
(H). The spectra shown in Figure 7 provide an interest-
ing example which will give information on the behav-
ior of this residue in a charged derivative. In the
charge-derivatized digestion products of phosphoenol-
pyruvate carboxykinase, a peak was observed in the
MALDI mass spectrum of an HPLC fraction with an m/z
value of 3945. The spectrum indicates that it is a
charged derivative. Figure 7A shows that the complete
sequence cannot be obtained, but this is not unusual for
a peptide of this size. (Perhaps a CID experiment would
yield additional fragment ions.) The m/z value did not
correlate with a predicted proteolytic digestion product.
The lower mass portion of the PSD spectrum is shown
in Figure 7B. The peaks as labeled indicate that the first
seven residues are GHHHHHH2. This also shows that
the His residue only yields an ions. The results show the
presence of a 6xHis tag, which is frequently introduced
to the N-terminus through a linker (DYDIPTTENLY-
FQG) to assist in purification following expression [18].
With the information that this peak represents the
N-terminal fragment, addition of the mass of the His-
tag and the linker to that expected for the N-terminal
digestion product provided a rationalization for the m/z
value of the C1 peak. From peaks present in the
spectrum, the seven residue His-tag and the next 16
residues could be identified. The ion intensities in the
higher mass region were insufficient to identify the last
eight residues, but a considerable amount of informa-
tion, and an explanation of the existence of the C1 ion,
was obtained from this interesting PSD spectrum. This
also shows that the presence of a His tag is easy to
locate using charged derivatives.
Finally, a comment should be made on peptides
containing cysteine residues. Phosphoenolpyruvate car-
boxykinase contains 532 residues; of these, four are
cysteines. As charge-derivatized peptides were located
and identified through their PSD spectra, we noted that
none of those found contained cysteine. The digestion
products are obviously present. One explanation might
be that they are not efficiently derivatized, however
chemistry at the N-terminus would probably not be so
dramatically influenced by the presence of a cysteine
elsewhere in the peptide. Another possibility is that a
charged TMPP1 2 Ac group is attached not only to the
N-terminus, but to cysteines as well. With one cysteine
present, this would yield a doubly charged analyte. The
MALDI experiment generates predominantly singly
charged species, and insufficient energy may be avail-
able to desorb a multiply charged ion from the con-
densed phase. If this is the case, electrospray ionization
may yield insights into multiply derivatized species,
because it does not appear to have the same limitations
concerning charge state of the ions formed. Preliminary
HPLC data for charge-derivatized cysteine-containing
peptides by Roth [19] suggests multiple derivatization.
When we generate the charged derivative of reduced
glutathione, [1]–ECG–OH, its MALDI-PSD spectrum
contains little information. However, a peak at m/z 607
is prominent. We believe this peak represents
TMPP1 2 Ac 2 SH ions, indicative of C derivatization.
We do note that a TMPP1 2 Ac derivatized peptide
containing cysteine has been formed and studied by
FAB [20]. In the spectrum reported, cysteine at position
two yielded a2 and d2 ions. Additional work remains in
determining the behavior of this residue in the solution
chemistry and subsequent gas phase chemistry.
Conclusions
The main hurdle of deriving peptide sequence from
tandem mass spectrometry is to identify all possible
Figure 7. (A) MALDI-PSD spectrum of the charge-derivatized
peptide containing the 6xHis tag. (B) The expanded low mass
region showing the an ion series from the leading His tag.
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fragment ion series. The unique advantage of the use of
charge-derivatized peptides is that their MALDI-PSD
spectra are dominated by an-type N-terminal fragment
ions, and there are no internal fragment ions formed.
We have observed different fragmentation processes for
individual amino acids within peptides, as summarized
in Table 1. Peptide sequence based on PSD spectra of
charged derivatives can be determined with a small
number of rules, at least for the charged group used in
this work.
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Table 1. Summary of residue-specific fragment ions from
MALDI-PSD-MS of charge-derivatized peptides
Amino acid
residue Reference [8] This work
Ala an
Arg [C1 2 156]a
Asn {cn, dn, an 2 17, an}
Asp {bn, dn, cn21}
Cys {an, dn}
b
Gln an
Glu an
Gly an
His an
Ile an
Leu an
Lys [C1 2 128]a
Met an
Phe an
Pro See c, below
Ser an
Thr {cn 2 1, an 2 44, an 2 16, an}
Trp an / [C
1 2 186]a
Tyr an
Val an
aArg, Lys, and Trp were observed as C-terminal residues.
bFAB data, [20].
cNone.
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